Pharmaceutical Business review

CytoCore signs distribution agreement with Mundinter

Mundinter’s agreement calls for minimum sales of 300k units the first year, 600k units the second, 1.0mm units the third, 1.1mm the fourth and minimum of 1.2mm units in the fifth year.

Robert McCullough Jr., CEO of CytoCore, said: “We are very pleased with this agreement as it adds to our developing momentum as the company ramps up distribution and sales. We are encouraged by the response from our European distributors, and expect the European markets will play a major role for our SoftPap collector as CytoCore continues to expand our distribution networks.”